Ad
related to: clinical trials for covid-19
Search results
Jacksonville research group seeks participants for new COVID-19 vaccine trial
WJXT Jacksonville· 28 minutes agoResearchers at the Jacksonville Center for Clinical Research (JCCR) are recruiting people to...
GeoVax to Present at BIO International Convention 2024
Digital Journal· 11 hours agoIn addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster ...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 15 hours agoAs a DPP1 inhibitor, brensocatib would be the first treatment in its class and could offer a...
Innovations in Breast Cancer Diagnosis and Treatment
New Jersey Business Magazine· 4 hours agoAlthough New Jersey is often ranked among the top 10 states in the nation for breast cancer incidence and mortality, the state’s healthcare institutions...
Achieving a High Performance, Diverse Accrual, Clinical Trial Program in an Academic Health System |...
JD Supra· 7 days agoAt the nexus of these advances are clinical trials. Trials are conducted in many types of clinical settings, but academic medical centers (AMCs), with their ...
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral...
St. Joseph News-Press· 14 hours agoSHELTON, CT / ACCESSWIRE / May 29, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the...
Not All COVID Patients Benefit From JAK Inhibitor
MedPage Today· 2 days agoPeople randomized to the Janus kinase (JAK) inhibitor baricitinib (Olumiant) to treat COVID-19 pneumonia in a clinical trial ...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace via Yahoo Finance· 7 days agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
BioNTech gets $145 million funding for African vaccine plants
Reuters via Yahoo News· 13 hours agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
Ocugen stock price analysis: good progress but a risky pattern forms | Invezz
Invezz· 8 hours agoIt has soared by over 177% this year, outperforming the S&P 500, Nasdaq 100, and the iShars...
